Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments

18 May 2021

Abstract excerpt

Gliomas are one of the most lethal types of cancers accounting for ∼80% of all central nervous system (CNS) primary malignancies. Among gliomas, glioblastomas (GBM) are the most aggressive, characterized by a median patient survival of fewer than 15 months. Recent molecular characterization studies uncovered the genetic signatures and methylation status of gliomas and correlate these with clinical prognosis. The...

Topics

Join the communities discussing this publication.

Glioma Diagnosis and Treatment
Immune cells in cancer
Neuroinflammation and Neurodegeneration Mechanisms

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 34084145
DOI: 10.3389/fphar.2021.680021

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical DevelopmentsPMID 34084145Read ↗

The Role of Neuro-Inflammation and Innate Immunity in Pathophysiology of Brain and Spinal Cord Tumors.Semantic proximity Read ↗

Deciphering Glioblastoma: Fundamental and Novel Insights into the Biology and Therapeutic Strategies of GliomasSemantic proximity Read ↗

Clinical Implications of Inflammation-Mediated Dysregulation of Glial Cell Fate: A Systematic Review for Early Brain Tumor Risk Detection and Improved Patient OutcomesSemantic proximity Read ↗

Glioma targeted therapy: insight into future of molecular approaches.Semantic proximity Read ↗

Glioblastoma IDH-wildtype: An integrative review of pathophysiological mechanisms, diagnostic innovations, and emerging therapeutic modalities.Semantic proximity Read ↗

The Dynamics of Interactions Among Immune and Glioblastoma Cells.Semantic proximity Read ↗

Immune Microenvironment in Glioblastoma Subtypes.Semantic proximity Read ↗

Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune CellsSemantic proximity Read ↗

Glioblastoma update: molecular biology, diagnosis, treatment, response assessment, and translational clinical trialsSemantic proximity Read ↗

BBB dysfunction drives neurotoxic myeloid cells in glioblastoma and Alzheimer’s diseaseSemantic proximity Read ↗

Molecular Heterogeneity and Immunosuppressive Microenvironment in GlioblastomaSemantic proximity Read ↗

Macrophages/Microglia in the Glioblastoma Tumor MicroenvironmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.